Affiliations 

  • 1 Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
  • 2 Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. shiota.masaki.101@m.kyushu-u.ac.jp
  • 3 Department of Urology, International University of Health and Welfare Ichikawa Hospital, Ichikawa, Japan
  • 4 Center for Urological Cancer, National Cancer Center, Goyang, South Korea
  • 5 College of Medicine, Yonsei University, Seoul, Republic of Korea
  • 6 Department of Urology, School of Medicine, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey
  • 7 Department of Urology, School of Medicine, Marmara University, Istanbul, Turkey
  • 8 Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 9 Department of Surgery, University of Malaya Specialist Centre, Kuala Lumpur, Malaysia
  • 10 Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China
  • 11 Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
  • 12 Department of Urology, Binh dan Hospital, Ho Chi Minh City, Vietnam
  • 13 Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
  • 14 Department of Urology, Cardinal Santos Medical Center, Manila, Philippines
  • 15 Department of Urology, Airlangga University/Dr. Soetomo General Hospital of Surabaya, Surabaya, East Java, Indonesia
  • 16 Department of Urology, National University of Singapore, Singapore, Singapore
  • 17 Division of Urology, Department of Special Surgery, Jordan University Hospital, the University of Jordan, Amman, Jordan
  • 18 Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • 19 Department of Urology, Graduate School of Medicine, Osaka University, Osaka, Japan
  • 20 Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan
  • 21 Department of Urology, School of Medicine, Teikyo University, Tokyo, Japan
  • 22 Department of Biostatistics and Clinical Epidemiology, Sapporo Medical University, Sapporo, Japan
World J Urol, 2025 Mar 04;43(1):146.
PMID: 40032670 DOI: 10.1007/s00345-025-05530-7

Abstract

PURPOSE: Prostate cancer is under-researched in many Asian countries because the paucity of comprehensive cancer registries has prevented large studies from comparing primary prostate cancer therapies. We aimed to provide further insights into recent trends in primary prostate cancer management across multiple Asian countries and regions according to universal health coverage.

METHODS: This is part of the Asian Prostate Cancer (A-CaP), a prospective and multicenter study conducted in 12 Asian countries. The study cohort comprised patients newly diagnosed between January 2016 and December 2018. Patients were allocated to three categories according to the universal health coverage effective coverage index (Category 1 ≥ 80; Category 2, 70-79; and Category 3, 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.